Genocea Biosciences, Inc.
GNCADelisted Jun 2, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001457612
Genocea Biosciences, Inc. was delisted on Jun 2, 2022; its insiders filed their last Form 4 on Jun 3, 2022; 40 institutions reported holding it in 13F filings for Q1 2022, worth $42.1M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Genocea Biosciences, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
GNCA is no longer listed, so this page shows Q1 2022. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 40
- −1 vs. Q4 2021
- Shares held
- 33.6M
- +112.9K (+0.3%) vs. Q4 2021
- Total value
- $42.1M
- +$3.16M (+8.1%) vs. Q4 2021
- New holders
- 3
- 11 more added
- Sold out
- 4
- 7 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GNCA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $1 |
| Q2 2024 | 1 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $1 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 1 | $4.00K |
| Q2 2022 | 5 | $92.0K |
| Q1 2022 | 40 | $42.1M |
| Q4 2021 | 41 | $38.9M |
| Q3 2021 | 40 | $65.3M |
| Q2 2021 | 46 | $79.4M |
| Q1 2021 | 42 | $86.3M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Genocea Biosciences, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 905 | $1.00K | 0.00% | −132−12.7% | Reduced |
| Cutler Group LP | 900 | $1.00K | 0.00% | 00.0% | Unchanged |
| Artemis Wealth Advisors, LLC | 1,137 | $1.00K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 900 | $1.00K | 0.00% | +900 | New |
| First Manhattan Co | 2,500 | $3.00K | 0.00% | 00.0% | Unchanged |
| ACT Capital Management, LLC | 5,000 | $6.00K | 0.01% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,847 | $7.00K | 0.00% | −211−3.5% | Reduced |
| Simplex Trading, LLC | 8,976 | $11.0K | 0.00% | −22,039−71.1% | Reduced |
| Two Sigma Advisers, LP | 10,000 | $13.0K | 0.00% | −12,677−55.9% | Reduced |
| Empirical Asset Management, LLC | 10,000 | $13.0K | 0.01% | 00.0% | Unchanged |
| Capital Asset Advisory Services LLC | 11,766 | $15.0K | 0.00% | 00.0% | Unchanged |
| WealthTrust Axiom LLC | 15,000 | $18.0K | 0.01% | 00.0% | Unchanged |
| Personal Capital Advisors Corp | 15,000 | $19.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 16,305 | $20.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 16,463 | $20.0K | 0.00% | +7,001+74.0% | Added |
| Jane Street Group, LLC | 18,433 | $23.0K | 0.00% | +18,433 | New |
| Boothbay Fund Management, LLC | 19,916 | $25.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 24,384 | $30.0K | 0.00% | +4,700+23.9% | Added |
| Morgan Stanley | 28,163 | $35.0K | 0.00% | +14,527+106.5% | Added |
| BIT Capital GmbH | 35,000 | $43.8K | 0.00% | +35,000 | New |
| Commonwealth Equity Services, LLC | 40,069 | $50.0K | 0.00% | +8,088+25.3% | Added |
| Renaissance Technologies LLC | 42,700 | $53.0K | 0.00% | +15,200+55.3% | Added |
| Group One Trading, L.P. | 50,517 | $63.0K | 0.00% | +6,503+14.8% | Added |
| Bank of America Corp | 57,363 | $72.0K | 0.00% | −270.0% | Reduced |
| Northern Trust Corp | 70,837 | $89.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 180,367 | $225.0K | 0.00% | −5,076−2.7% | Reduced |
| Ikarian Capital, LLC | 206,336 | $259.0K | 0.08% | +9,515+4.8% | Added |
| HighTower Advisors, LLC | 212,260 | $266.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 215,002 | $269.0K | 0.00% | +18,569+9.5% | Added |
| Geode Capital Management, LLC | 291,733 | $364.0K | 0.00% | +84,853+41.0% | Added |
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $469.0K | 32.06% | 00.0% | Unchanged |
| Boxer Capital, LLC | 1,134,453 | $1.42M | 0.07% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,574,979 | $1.97M | 0.00% | +1000.0% | Added |
| Citadel Advisors LLC | 1,843,112 | $2.30M | 0.00% | +47,617+2.7% | Added |
| Kingdon Capital Management, L.L.C. | 1,972,056 | $2.46M | 0.42% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 2,576,385 | $3.22M | 0.01% | −76,589−2.9% | Reduced |
| Commodore Capital LP | 3,079,756 | $3.85M | 0.86% | 00.0% | Unchanged |
| BVF Inc | 4,012,404 | $5.02M | 0.20% | 00.0% | Unchanged |
| Avoro Capital Advisors LLC | 5,084,184 | $6.36M | 0.12% | 00.0% | Unchanged |
| NEA Management Company, LLC | 10,376,936 | $13.0M | 0.42% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −21,741−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,503−100.0% | Sold out |
| Vectors Research Management, LLC | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,129−100.0% | Sold out |